Cybin, MindMed, and Field Trip Health Headline PSYC's First CEO Round Table Event
February 14 2022 - 8:30AM
InvestorsHub NewsWire
Cybin, MindMed, and
Field Trip Health Headline PSYC’s First CEO Round Table
Event
LAKE OSWEGO,OR -- February 14,
2022 -- InvestorsHub NewsWire -- Global Trac Solutions,
Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) a media leader for the
emerging medicinal psychedelics sector, and authorities
behind Psychedelic
Spotlight, a top ranking
psychedelic news and information platform, is pleased to announce
that Psychedelic Spotlight will host its first “CEO
Roundtable” on Tuesday, February 15, 2022 at 9:30 am
EST.
The event is scheduled to be
streamed live on YouTube via The Psychedelic
Investor (*) channel, and will be moderated by James Hallifax,
Journalist and Content Director for Psychedelic Spotlight. Three of
the most prominent leaders of drug development companies within the
burgeoning medicinal psychedelic industry will be featured: Doug
Drysdale, CEO of Cybin Corp.
(NYSE: CYBN), Robert Barrow, CEO and
Board Director of MindMed (NASDAQ: MNMD), and Ronan Levy Co-Founder and
Executive Chairman of Field Trip Health
(NASDAQ:
FTRP).
Several highly relevant,
industry-focused topics are expected to be covered and discussed
openly amongst the participants during the event, including the
present state of the medicinal psychedelic industry and challenges
that remain present, along with its growth outlook and value
potential over the next couple of
years.
“We are thrilled for this
incredible opportunity to bring the leaders of MindMed, Cybin and
Field Trip together for one event,” said James Hallifax, Journalist
and Content Director for Psychedelic Spotlight. “I’m not sure that
there’s ever been a live digital conference with such a high
caliber of business leaders in the psychedelics space. I am excited
to hear these executives discuss, amongst themselves, the future of
this industry and on which topics they agree and disagree. Everyone
watching will get an unparalleled opportunity to learn exactly
where the medicinal psychedelic space is going in the near
future.”
PSYC CEO, David
Flores, said, “Our core focus in 2022 is to fully maximize our
growing presence within the medicinal psychedelic industry through
our amazing Psychedelic Spotlight platform in order to solidify our
position as a leading informational hub for this space. Not only do
I see l this “CEO Roundtable”
as an excellent opportunity for us
to further strengthen our authority within the industry by bringing
together leaders from three of the most influential psychedelic
drug discovery companies on the market, but I believe it will also
serve as a blueprint to utilize in the development of future,
monetizable events hosted by Psychedelic Spotlight and The
Psychedelic Investor. Huge thanks to Cybin, MindMed, and Field Trip
Health for lending us their talented leaders for this event. We
hope it will help shine a spotlight on some of the exciting things
they’re working on, respectively, while simultaneously
demonstrating the tremendous growth and value potential, we
believe, is being unlocked by this revolutionary
industry.”
To live stream the event, please
visit The Psychedelic Investor YouTube channel
at 9:30 am EST on February 15, 2022. The
Company also plans to also make the recording of the event
available to view on its Psychedelic Spotlight website shortly
after it is completed.
(*) The Psychedelic Investor is an asset
owned and operated by PSYC
About Global Trac Solutions, Inc.
(OTCPink:
PSYC)
At Global Trac Solutions we are
integrating media, creativity, and technology to develop and deploy
thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society’s most pressing
matters.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, we believe investors are speculating that the
psychedelic boom could be bigger than that of cannabis. PSYC is
your source for current investment related news specific to
psychedelic medicines and cutting-edge research improving overall
health, moving this sector into the mainstream.
We are dedicated to a
forward-thinking approach that embraces groundbreaking new
technology and innovations and through the vision of business
development we intend to continue to evolve into these unchartered
territories as the industry leaders of the future. We contend that
we are truly the right TRAC to follow.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, that
may cause our results, levels of activity, performance or
achievements to be materially different from the information
expressed or implied by the forward-looking statements in this
press release. This press release should be considered in light of
all filings of the Company that are disclosed on the OTC
Markets.com website.
Disclaimer: Global Trac
Solutions, Inc. does not in any way encourage or condone the use,
purchase, sale or transfer of any illegal substances, nor do we
encourage or condone partaking in any unlawful activities. We
support a harm reduction approach for the purpose of education and
promoting individual and public safety. If you are choosing to use
psychedelic substances, please do so
responsibly.
Corporate
Contact:
Global Trac Solutions, Inc.
(PSYC)
www.globaltracsolutions.com
(702) 239-1919
psyc@globaltracsolutions.com
OTCPINK: PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Apr 2023 to Apr 2024